Search filters

List of works by Manu Vandijck

Alzheimer Disease Biomarker Testing in Cerebrospinal Fluid: A Method to Harmonize Assay Platforms in the Absence of an Absolute Reference Standard ⬇️

scientific article published on January 25, 2013

Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects

scientific article

Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements

article

CSF biomarker variability in the Alzheimer's Association quality control program

scientific article published on May 2013

Cerebrospinal fluid growth-associated protein 43 in multiple sclerosis

scientific article published on 21 November 2019

Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease

scientific article published on 13 March 2013

Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurements

scientific article published on 01 November 2018

Concordance of Lumipulse cerebrospinal fluid t-tau/Aβ42 ratio with amyloid PET status

scientific article published on 01 January 2020

Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology

scientific article published on 12 October 2018

First amyloid β1-42 certified reference material for re-calibrating commercial immunoassays

scientific article published on 04 August 2020

Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: an update from the Alzheimer's Association Global Biomarkers Consortium

scientific article published on 28 December 2012

Increased CSF α-synuclein levels in Alzheimer's disease: correlation with tau levels

scientific article

The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review

scientific article published on 23 June 2018

Transient increase in CSF GAP-43 concentration after ischemic stroke

Validation and Clinical Utility of ELISA Methods for Quantification of Amyloid-β of Peptides in Cerebrospinal Fluid Specimens from Alzheimer’s Disease Studies.

scientific article

Paulina is supported by:

About Paulina

Help